Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous platelet-rich plasma (PRP) dressing is a biological therapy derived from a patient's own peripheral blood, processed via centrifugation to achieve a high concentration of platelets. This concentrated plasma is applied topically to chronic, non-healing wounds to facilitate the delivery of a potent cocktail of endogenous growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF). These factors stimulate essential regenerative processes such as angiogenesis, fibroblast proliferation, and collagen synthesis. Multan Medical and Dental College is investigating this intervention in a randomized controlled trial for the treatment of various chronic cutaneous ulcers, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, aiming to demonstrate superior healing rates compared to standard saline dressings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autologous platelet-rich plasma dressing.